Wednesday, July 12, 2017

British Journal of Cancer - Table of Contents alert Volume 117 Issue 1

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 117, Issue 2 (157-300)
Published online 11 July 2017

In this issue
Editorial
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology
Letters to the Editor

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Editorial

Top

Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?

N LeVasseur and S K Chia

Br J Cancer 2017 117: 157-300; advance online publication, June 22, 2017; 10.1038/bjc.2017.176

Full Text

Minireview

Top

Akt as a target for cancer therapy: more is not always better (lessons from studies in mice)

Qi Wang, Xinyu Chen and Nissim Hay

Br J Cancer 2017 117: 159-163; advance online publication, May 30, 2017; 10.1038/bjc.2017.153

Abstract | Full Text

Clinical Studies

Top

Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group

Dimitrios Mavroudis, Emmanouil Saloustros, Ioannis Boukovinas, Pavlos Papakotoulas, Stylianos Kakolyris, Nikolaos Ziras, Charalampos Christophylakis, Nikolaos Kentepozidis, Georgios Fountzilas, Georgios Rigas, Ioannis Varthalitis, Konstantinos Kalbakis, Sofia Agelaki, Dora Hatzidaki and Vasilios Georgoulias

Br J Cancer 2017 117: 164-170; advance online publication, June 22, 2017; 10.1038/bjc.2017.158

Abstract | Full Text

Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study

Gabrielle M Haeusler, Karin A Thursky, Francoise Mechinaud, Franz E Babl, Richard De Abreu Lourenco, Monica A Slavin and Robert Phillips

Br J Cancer 2017 117: 171-178; advance online publication, June 13, 2017; 10.1038/bjc.2017.154

Abstract | Full Text

The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival

Marissa C van Maaren, Reini W Bretveld, Jan J Jobsen, Renske K Veenstra, Catharina GM Groothuis-Oudshoorn, Hendrik Struikmans, John H Maduro, Luc JA Strobbe, Philip MP Poortmans and Sabine Siesling

Br J Cancer 2017 117: 179-188; advance online publication, June 6, 2017; 10.1038/bjc.2017.159

Abstract | Full Text

Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment

Richard Kim, E Gabriela Chiorean, Manik Amin, Caio Max S Rocha-Lima, Jitendra Gandhi, William P Harris, Tao Song and David Portnoy

Br J Cancer 2017 117: 189-194; advance online publication, June 20, 2017; 10.1038/bjc.2017.160

Abstract | Full Text

Translational Therapeutics

Top

Pharmacologically directed strategies in academic anticancer drug discovery based on the European NCI compounds initiative

Hans R Hendriks, Anne-Sophie Govaerts, Iduna Fichtner, Sally Burtles, Andrew D Westwell and Godefridus J Peters on behalf of the EORTC-PAMM Group

Br J Cancer 2017 117: 195-202; advance online publication, June 13, 2017; 10.1038/bjc.2017.167

Abstract | Full Text

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies

Muhammad A Alvi, Maurice B Loughrey, Philip Dunne, Stephen McQuaid, Richard Turkington, Marc-Aurel Fuchs, Claire McGready, Victoria Bingham, Brendan Pang, Wendy Moore, Perry Maxwell, Mark Lawler, Jacqueline A James, Graeme I Murray, Richard H Wilson and Manuel Salto-Tellez

Br J Cancer 2017 117: 203-209; advance online publication, June 8, 2017; 10.1038/bjc.2017.168

Abstract | Full Text

Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy

K J Gash, A C Chambers, D E Cotton, A C Williams and M G Thomas

Br J Cancer 2017 117: 210-219; advance online publication, June 22, 2017; 10.1038/bjc.2017.175

Abstract | Full Text

Molecular Diagnostics

Top

Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer

Daniel Kazdal, Alexander Harms, Volker Endris, Roland Penzel, Mark Kriegsmann, Florian Eichhorn, Thomas Muley, Albrecht Stenzinger, Nicole Pfarr, Wilko Weichert and Arne Warth

Br J Cancer 2017 117: 220-226; advance online publication, May 30, 2017; 10.1038/bjc.2017.155

Abstract | Full Text

Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer

Tsuyoshi Hata, Ichiro Takemasa, Hidekazu Takahashi, Naotsugu Haraguchi, Junichi Nishimura, Taishi Hata, Tsunekazu Mizushima, Yuichiro Doki and Masaki Mori

Br J Cancer 2017 117: 227-232; advance online publication, June 20, 2017; 10.1038/bjc.2017.163

Abstract | Full Text

MicroRNA-199b-5p attenuates TGF-β1-induced epithelial–mesenchymal transition in hepatocellular carcinoma

Shao-jun Zhou, Fu-yao Liu, An-hong Zhang, Hui-fang Liang, Ye Wang, Rong Ma, Yuan-hui Jiang and Nian-feng Sun

Br J Cancer 2017 117: 233-244; advance online publication, June 6, 2017; 10.1038/bjc.2017.164

Abstract | Full Text

KIF15 promotes pancreatic cancer proliferation via the MEK–ERK signalling pathway

Jie Wang, Xingjun Guo, Chencheng Xie and Jianxin Jiang

Br J Cancer 2017 117: 245-255; advance online publication, June 8, 2017; 10.1038/bjc.2017.165

Abstract | Full Text

Genetics & Genomics

Top

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

Maribel Forero-Castro, Cristina Robledo, Rocío Benito, Irene Bodega-Mayor, Inmaculada Rapado, María Hernández-Sánchez, María Abáigar, Jesús Maria Hernández-Sánchez, Miguel Quijada-Álamo, José María Sánchez-Pina, Mónica Sala-Valdés, Fernanda Araujo-Silva, Alexander Kohlmann, José Luis Fuster, Maryam Arefi, Natalia de las Heras, Susana Riesco, Juan N Rodríguez, Lourdes Hermosín, Jordi Ribera, Mireia Camos Guijosa, Manuel Ramírez, Cristina Díaz de Heredia Rubio, Eva Barragán, Joaquín Martínez, José M Ribera, Elena Fernández-Ruiz and Jesús-María Hernández-Rivas

Br J Cancer 2017 117: 256-265; advance online publication, May 30, 2017; 10.1038/bjc.2017.152

Abstract | Full Text

Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331

Marek Sierzega, Marcin Kaczor, Piotr Kolodziejczyk, Jan Kulig, Marek Sanak and Piotr Richter

Br J Cancer 2017 117: 266-273; advance online publication, June 22, 2017; 10.1038/bjc.2017.190

Abstract | Full Text

Epidemiology

Top

Prioritising action on occupational carcinogens in Europe: a socioeconomic and health impact assessment

J W Cherrie, S Hutchings, M Gorman Ng, R Mistry, C Corden, J Lamb, A Sánchez Jiménez, A Shafrir, M Sobey, M van Tongeren and L Rushton

Br J Cancer 2017 117: 274-281; advance online publication, June 13, 2017; 10.1038/bjc.2017.161

Abstract | Full Text

Impact of body mass index on ovarian cancer survival varies by stage

Elisa V Bandera, Valerie S Lee, Bo Qin, Lorna Rodriguez-Rodriguez, C Bethan Powell and Lawrence H Kushi

Br J Cancer 2017 117: 282-289; advance online publication, June 6, 2017; 10.1038/bjc.2017.162

Abstract | Full Text

Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study

Chaya S Moskowitz, Joanne F Chou, Charles A Sklar, Dana Barnea, Cécile M Ronckers, Danielle Novetsky Friedman, Joseph P Neglia, Lucie Turcotte, Rebecca M Howell, Tara O Henderson, Gregory T Armstrong, Wendy M Leisenring, Leslie L Robison, Flora E van Leeuwen, Malcolm C Pike and Kevin C Oeffinger

Br J Cancer 2017 117: 290-299; advance online publication, June 20, 2017; 10.1038/bjc.2017.169

Abstract | Full Text

Letters to the Editor

Top

Comment on ‘Renewed interest in the progesterone receptor in breast cancer’

Giovanni Simone, Sergio Diotaiuti, Maria Digennaro, Domenico Sambiasi, Simona De Summa, Stefania Tommasi, Rosanna Altieri, Annita Mangia, Caterina Dantona and Angelo Paradiso

Br J Cancer 2017 117: e1; advance online publication, April 11, 2017; 10.1038/bjc.2017.90

Full Text

Comment on ‘Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study’

Anthony B Miller

Br J Cancer 2017 117: e2; advance online publication, April 11, 2017; 10.1038/bjc.2017.101

Full Text

Comment on 'The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis'

Alain Braillon

Br J Cancer 2017 117: e3; advance online publication, June 22, 2017; 10.1038/bjc.2017.184

Full Text

Reply to ‘Comment on ‘The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis’’

L Zgaga, P G Vaughan-Shaw, F O’Sullivan, S M Farrington, E Theodoratou, H Campbell and M G Dunlop

Br J Cancer 2017 117: e4; advance online publication, June 22, 2017; 10.1038/bjc.2017.185

Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: